scanX
Syngene International
add_icon

Syngene International

477.35
+9.70
(2.07%)
Market Cap
19,234.31 Cr
PE Ratio
59.53
Volume
43,50,079.00
Day High - Low
492.25 - 453.60
52W High-Low
728.60 - 380.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
19,234.31 Cr
EPS
7.87
PE Ratio
59.53
PB Ratio
3.90
Book Value
120.10
EBITDA
841.90
Dividend Yield
0.27 %
Industry
Healthcare
Sector
Healthcare Technology
Return on Equity
10.50
Debt to Equity
0.13
Analyst Rating and Forecast
- By Refinitiv from8 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+62.50 %
+62.50 %
Hold
Hold+25.00 %
+25.00 %
Sell
Sell+12.50 %
+12.50 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Syngene Q4 FY26: Revenue Rises, Profit Falls1 day ago
Syngene International reported Q4 FY26 revenue of Rs 10,365 million (+2% YoY) with consolidated PAT at Rs 1,479 million (-19% YoY). EBITDA margin declined to 30.8% from 35.0%. Board recommended final dividend of Rs 1.25 per share.
neutral
Syngene International Block Trade Worth ₹41.20 Cr4 days ago
Syngene International witnessed a significant NSE block trade of ₹41.20 crores involving approximately 797,278 shares at ₹516.80 per share, indicating substantial institutional activity.
neutral
Syngene FY26: Revenue Up 3%, Profit Down 20%4 days ago
Syngene International reported FY26 revenue growth of 3% to ₹37,387 million, but profit declined 20% to ₹3,167 million. Q4 EBITDA margin compressed to 29% amid operational challenges.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Syngene International
477.35
#1 19,234.31
#4 59.53
#1 3,738.70
#6 0.66
#2 324
#4 -19.31
67.74
Indegene
533.35
12,843.49
#1 30.00
3,510.50
19.14
#1 349
-32.23
70.62
Suven Life Sciences
212.42
5,601.95
-20.33
17.60
-46.34
-161
-160.61
69.21
Vimta Labs
476.40
2,128.05
35.09
322.30
0.22
41
112.87
59.09
Take Solutions
40.56
600.02
386.18
10.20
#1 126.67
1
-97.69
36.68
Jeevan Scientific Technology
82.11
163.56
-78.92
47.50
17.87
0
#1 2,300.00
66.02
Bilcare
62.30
146.69
-3.47
806.50
4.78
-56
20.99
-
Adeshwar Meditex
15.45
22.30
33.09
84.00
5.00
2
-83.33
21.41
Vanta Bioscience
18.30
13.06
-0.87
2.10
-78.57
-13
-450.00
51.39

Automatic Screeners on ScanX

Community
5% Fall from Low
Growth Rate
Revenue Growth
0.66 %
Net Income Growth
-34.72 %
Cash Flow Change
12.04 %
ROE
-12.35 %
ROCE
-1.05 %
EBITDA Margin (Avg.)
-26.28 %

Quarterly Financial Results

Quarterly Financials
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
399
426
425
437
484
555
441
557
539
628
437
533
602
712
607
623
654
773
660
784
803
1,017
832
932
883
933
840
908
962
1,037
892
926
933
1,059
Expenses
262
280
297
292
327
374
300
325
366
403
297
364
408
443
430
464
438
508
472
552
555
680
596
663
626
600
620
646
660
674
668
711
779
739
EBITDA
138
146
128
145
158
181
142
231
174
225
140
170
193
269
177
160
216
265
188
232
248
337
236
268
257
333
220
261
302
363
224
215
154
320
Operating Profit %
33 %
32 %
27 %
30 %
30 %
30 %
29 %
30 %
30 %
34 %
30 %
30 %
30 %
33 %
28 %
24 %
32 %
33 %
27 %
28 %
29 %
32 %
26 %
27 %
27 %
35 %
22 %
27 %
30 %
34 %
24 %
22 %
15 %
29 %
Depreciation
35
34
37
40
43
44
47
53
57
62
66
69
70
70
75
76
79
80
86
90
95
96
102
105
108
111
107
111
109
106
111
117
114
112
Interest
5
7
8
8
8
8
7
8
10
9
7
7
7
7
8
1
9
6
9
12
14
10
11
13
11
13
12
13
12
16
12
13
12
12
Profit Before Tax
98
104
83
97
107
129
87
170
107
153
66
94
117
192
95
82
128
179
93
130
140
231
123
151
138
209
101
137
181
241
101
85
28
196
Tax
16
20
17
19
20
29
15
42
15
33
8
10
14
32
17
16
24
31
19
28
30
52
30
34
27
20
26
31
50
57
15
18
13
48
Net Profit
82
85
66
78
87
100
72
128
92
120
58
84
102
161
77
67
104
148
74
102
110
179
93
117
112
189
76
106
131
183
87
67
15
148
EPS in ₹
4.14
4.27
3.34
3.96
2.20
2.53
1.82
3.23
2.32
3.03
1.47
2.12
2.57
4.04
1.91
1.64
2.57
3.71
1.85
2.55
2.74
4.36
2.33
2.90
2.78
4.70
1.89
2.64
3.27
4.56
2.16
1.67
0.37
3.68
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
3,189
3,704
4,163
4,883
5,564
5,831
6,152
6,796
7,055
Fixed Assets
1,030
1,377
2,020
2,201
2,393
2,667
2,850
2,802
4,046
Current Assets
1,720
1,764
1,613
1,807
2,206
2,425
1,959
2,287
2,143
Capital Work in Progress
155
274
234
237
346
177
838
1,266
1,040
Investments
158
716
776
702
1,034
919
548
647
141
Other Assets
1,846
1,337
1,133
1,743
1,791
2,069
1,916
2,081
0
Total Equity & Liabilities
3,189
3,704
4,163
4,883
5,564
5,831
6,152
6,796
7,055
Current Liabilities
784
1,129
1,539
1,133
1,229
1,188
1,144
1,396
1,552
Non Current Liabilities
685
607
448
929
1,037
1,025
750
673
663
Total Equity
1,720
1,968
2,176
2,821
3,298
3,618
4,258
4,727
4,839
Reserve & Surplus
1,520
1,768
1,776
2,421
2,897
3,217
3,856
4,324
4,436
Share Capital
200
200
400
400
401
401
402
403
403
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
18
-88
28
130
-62
-172
-4
281
Investing Activities
-349
-646
-424
-629
-611
-653
-495
-744
Operating Activities
446
630
677
701
581
824
1,042
1,168
Financing Activities
-79
-72
-226
58
-31
-343
-551
-142
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
70.58 %
70.43 %
70.42 %
70.41 %
70.41 %
70.29 %
64.86 %
64.86 %
54.88 %
54.80 %
54.79 %
54.79 %
54.79 %
54.72 %
54.72 %
52.74 %
52.74 %
52.68 %
52.68 %
52.68 %
52.68 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.02 %
0.02 %
0.00 %
0.00 %
0.00 %
20.92 %
20.63 %
20.72 %
20.64 %
19.47 %
16.50 %
16.31 %
14.96 %
13.90 %
DIIs
4.02 %
3.81 %
4.03 %
3.64 %
3.26 %
2.79 %
4.96 %
7.04 %
10.73 %
11.20 %
9.94 %
13.08 %
15.80 %
16.80 %
17.48 %
19.53 %
21.50 %
24.05 %
24.62 %
25.84 %
26.44 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.05 %
8.29 %
8.46 %
9.20 %
9.22 %
9.02 %
8.81 %
8.57 %
8.39 %
8.10 %
7.53 %
7.24 %
6.45 %
6.08 %
5.45 %
5.59 %
5.08 %
5.59 %
5.28 %
5.37 %
5.51 %
Others
17.35 %
17.46 %
17.09 %
16.76 %
17.11 %
17.90 %
21.36 %
19.52 %
25.98 %
25.90 %
27.73 %
24.89 %
2.03 %
1.77 %
1.62 %
1.50 %
1.21 %
1.18 %
1.10 %
1.15 %
1.46 %
No of Share Holders
1,15,632
1,26,395
1,36,749
1,37,892
1,33,610
1,28,278
1,34,334
1,27,964
1,24,014
1,25,455
1,25,992
1,21,880
1,15,850
1,20,018
1,07,338
1,28,806
1,25,090
1,42,310
1,36,061
1,31,750
1,35,605

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 1 1 0.5 0.00 0.00 1 1.25 1.25 1.25 0.00
Dividend Yield (%) 0.33 0.34 0.21 0.00 0.00 0.17 0.18 0.17 0.32 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Jul 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
 29 Jul 2026 440.00 467.90
12 Jun 2019 BONUS Bonus
1:1
 11 Jun 2019 340.05 336.35
01 Jul 2022 DIVIDEND Dividend
₹ 0.50 /share
 30 Jun 2022 627.50 554.75
01 Jul 2022 DIVIDEND Dividend
₹ 0.50 /share
 30 Jun 2022 627.50 554.75
30 Jun 2023 DIVIDEND Dividend
₹ 0.50 /share
 30 Jun 2023 625.90 759.60
30 Jun 2023 DIVIDEND Dividend
₹ 0.75 /share
 30 Jun 2023 625.90 759.60
28 Jun 2024 DIVIDEND Dividend
₹ 1.25 /share
 28 Jun 2024 701.05 713.15
24 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
 24 Jul 2024 701.05 757.75
23 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Oct 2024 884.35 838.90
23 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Jan 2025 859.80 828.15
23 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Apr 2025 697.45 735.45
27 Jun 2025 DIVIDEND Dividend
₹ 1.25 /share
 27 Jun 2025 735.45 645.85
23 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 23 Jul 2025 735.45 676.25
23 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 23 Jul 2025 634.20 676.25
05 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 05 Nov 2025 630.65 646.55
22 Jan 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 22 Jan 2026 656.75 600.85
29 Apr 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 29 Apr 2026 402.95 440.00

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome4 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation4 days ago
Syngene International Limited Has Informed The Exchange That Record Date For The Purpose Of Dividend Is June 26 2026.4 days ago
Intimation Of Change In Key Managerial Personnel (KMP) To Determine Materiality Of An Event Or Information4 days ago
Allotment4 days ago
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s4 days ago
Announcement under Regulation 30 (LODR)-Change in Management4 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
Announcement under Regulation 30 (LODR)-Dividend Updates4 days ago
Board Meeting Outcome for Syngene International Limited Has Submitted To The Exchange The Financial Results For The Period Ended March 31 2026.4 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 22, 2026
Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results For The Quarter And Year Ending March 31 2026; And To Consider The Recommendation Of Final Dividend If Any.Apr 15, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Apr 15, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Apr 10, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 29, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 27, 2026
Closure of Trading WindowMar 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 16, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 11, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 20, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 18, 2026
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011Feb 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 14, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 14, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 24, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJan 23, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationJan 23, 2026
Board Comments On Fine Levied By The Exchanges.Jan 22, 2026
Intimation Of Amendment Of Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information (UPSI) Of The Company.Jan 22, 2026
Board Meeting Outcome for Outcome Of The Board Meeting - January 22 2026.Jan 22, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 22, 2026
Unaudited Financial Results For Quarter & Nine Months Ended December 31 2025.Jan 22, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 17, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 09, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ending December 31 2025.Jan 08, 2026
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Dec 30, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
JioBlackRock Nifty Smallcap 250 Index Fund Direct-Growth
0.44%
31830
0.44%
0.44%
Tata Nifty Midcap 150 Index Fund Direct-Growth
0.00%
-11480
-0.21%
-0.24%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth
0.00%
-11122
-0.21%
-0.24%
Unifi Dynamic Asset Allocation Fund Direct-Growth
0.00%
-7000
-0.03%
0.00%
Kotak Nifty Midcap 150 Index Fund Direct-Growth
0.00%
-1078
-0.21%
-0.24%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.43%
841
0.43%
0.43%
Groww Nifty Midcap 150 Index Fund Direct-Growth
0.00%
-619
-0.21%
-0.24%
DSP Nifty Midcap 150 Index Fund Direct-Growth
0.00%
-494
-0.21%
-0.24%
JioBlackRock Sector Rotation Fund Direct-Growth
0.06%
320
0.00%
0.06%
UTI Nifty500 Shariah Index Fund Direct-Growth
0.14%
97
0.00%
0.14%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth
0.14%
-58
0.00%
-0.02%
DSP Nifty Healthcare Index Fund Direct-Growth
0.77%
-44
-0.03%
-0.19%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.04%
16
0.00%
0.00%
DSP Nifty 500 Index Fund Direct-Growth
0.04%
14
0.00%
-0.01%
Invesco India Arbitrage Fund Direct-Growth
0.00%
0
0.00%
-0.15%
Groww Nifty Total Market Index Fund Direct-Growth
0.04%
0
0.00%
0.00%
Bandhan Large & Mid Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Large Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Multi Asset Allocation Fund Direct-Growth
0.27%
0
0.00%
0.20%
Bandhan Multi Cap Fund Direct-Growth
0.27%
0
0.00%
0.16%
Bandhan Nifty Midcap 150 Index Fund Direct-Growth
0.00%
0
0.00%
-0.21%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.44%
0
0.00%
0.44%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.04%
0
0.00%
0.00%
Bandhan Value Fund Direct-Growth
0.31%
0
0.00%
0.10%
Baroda BNP Paribas Arbitrage Fund Direct-Growth
0.00%
0
0.00%
0.00%

Technical Indicators

RSI(14)
Neutral
65.37
ATR(14)
Volatile
20.85
STOCH(9,6)
Neutral
57.48
STOCH RSI(14)
Overbought
80.34
MACD(12,26)
Bullish
4.72
ADX(14)
Weak Trend
22.91
UO(9)
Bearish
44.23
ROC(12)
Uptrend And Accelerating
16.09
WillR(14)
Neutral
-40.14
Bearish
3
Neutral
4
Bullish
2

About Syngene International

Syngene International Limited is an integrated research, development, and manufacturing services company headquartered in India. It serves global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The company operates across four business divisions: Discovery Services, Development Services, Manufacturing Services, and Dedicated Centers. With approximately 6000 scientists, Syngene...more
Listing Date
11 Aug, 2015(10 Years, 23 days)
Website
https://www.syngeneintl.com
Chairperson NameKiran Mazumdar Shaw
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104